No attachments available.
Partek Flow Floating License Software Package, renewal year base with 2 options
Contact and place of performance
Dana Monroe
Bethesda, MD 20892
USA
Pre-Solicitation Notice – Notice of Intent to award on a Single Source Basis Title: Notice of Intent to Award a Single Source Purchase Order for the Renewal of One (1) Floating License for a computational Partek Flow Software Package for Large Scale Statistical Analysis and Data Mining – base year with 2 options. Notice Number: NOI_PCA-NIAMS-06946 Agency: Department of Health and Human Services, Nati...
View moreNIH/NIAMS has a requirement for renewal of one (1) Floating License for a computational Partek Flow Software Package for Large Scale Statistical Analysis and Data Mining. The requirement being sought covers a base year plus two (2) subsequent option years.
Base Year: 08/10/2026 – 08/09/2027
Option Year 1: 08/10/2027 – 08/09/2028
Option Year 2: 08/10/2028 – 08/09/2029
Requirement Details:
Partek Flow is an advanced platform for large-scale genomics data analysis. Its Enterprise Edition supports a wide range of applications, including bulk RNA-seq, DNA-seq, ChIP-seq/ATAC-seq, microarray, and metagenomics. Add-on modules for single-cell and spatial data analysis are essential to meet the needs of multiple NIAMS Intramural Research Program (IRP) projects. Notably, recently developed tools for spatial single-cell RNA-seq analysis provide enhanced statistical and exploratory capabilities, significantly expanding the platform’s single-cell omics functionality. These add-ons are a critical complement to the Enterprise Edition and provide substantial value to the Biodata Mining and Discovery Section (BDMS) and other NIAMS IRP researchers.
Justification for Sole Source:
Proprietary Technology: Partek Inc., now part of Illumina, is the sole developer and distributor of Partek Flow and its associated add-on tools, making it the only source for this software package. Licensing for the Partek Flow Toolkit includes ongoing feature enhancements and implementation of new functionalities throughout the license period. The platform offers advanced computational tools for analyzing complex genomics datasets, including CITE-seq, single-cell gene expression, ATAC-seq, and spatial transcriptomics. These capabilities are essential to the research conducted by BDMS (Biodata Mining and Discovery Section) within the NIAMS Intermural Research Program.
Continuity of Service and Patient Data: BDMS initially acquired Partek Flow within the past five years to support high-throughput sequencing data analysis and has since integrated it as a core component of its bioinformatics workflows. Its use has enabled efficient processing, integration, and analysis of diverse and complex datasets, significantly enhanced research productivity and supporting reproducible, high-quality results.
Avoidance of Unacceptable Risk and Cost: Continued access to Partek Flow is critical to avoid disruption to ongoing projects and to maintain essential analytical capabilities for BDMS and other NIAMS IRP researchers. The platform is also widely adopted across NIH institutes, including NCI, NIDDK, NIAID, NCATS, and NIEHS, underscoring its reliability and value within the broader research community.
This is a Notice of Intent, not a request for quotation (RFQ). A solicitation document will not be issued, and quotations will not be requested. This notice is not a request for competitive quotes. However, all responsible sources who believe they can meet the requirement as stated herein may submit a capability statement, proposal, or quotation which shall be considered by the agency. A determination by the Government not to compete this proposed contract action based upon responses to this notice is solely within the discretion of the Government.
Submission Instructions:
Interested parties must identify their interest and prove their capability to respond to this requirement by the response date. All responses should be submitted electronically to the primary point of contact listed below. The response should include sufficient technical information to allow for a Government review and determination of capability.
Primary Point of Contact:
Dana Monroe
Contract Specialist
Office of Mission Acquisition Solutions (OMAS)
Office of Acquisitions (OA) | Assistant Secretary for Financial Resources (ASFR)
U.S. Department of Health and Human Services
12.201-1, Simplified procedures
12.205 Solicitation provisions and contract clauses.
41 USC 1901: Simplified acquisition procedures
52.212-1, Instructions to Offerors—Commercial Products and Commercial Services
17.203 Solicitation provisions and contract clauses.
The Department of Health and Human Services, National Institutes of Health (NIH), National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) intends to award a single source, firm-fixed-price purchase order to Illumina, Inc. for the renewal of one floating license for the Partek Flow software package. This computational platform facilitates large-scale statistical analysis and data mining, supporting genomics applications such as bulk RNA-seq, DNA-seq, microarray, and metagenomics. The requirement includes add-on modules for single-cell and spatial data analysis, which are critical for the Biodata Mining and Discovery Section (BDMS) and other Intramural Research Program projects.
The procurement is classified under NAICS code 513210, Software Publishers, and PSC code 6632, Analysis Instruments, Medical Laboratory Use. The performance period consists of a base year running from August 10, 2026, to August 9, 2027, followed by two successive one-year options. Performance will take place in Bethesda, Maryland. As the sole developer and distributor of the proprietary Partek Flow toolkit, Illumina, Inc. is identified as the only source capable of providing the necessary software enhancements and maintaining continuity for existing bioinformatics workflows integrated across multiple NIH institutes.
This pre-solicitation notice, identified by solicitation number NOI_PCA-NIAMS-06946, indicates that the government does not intend to issue a competitive request for quotation. However, responsible sources may submit a capability statement or proposal for consideration by May 26, 2026, at 1:00 PM MST. Submissions must include sufficient technical information to demonstrate the provider's ability to meet the requirement and should be directed to Dana Monroe at the Office of Mission Acquisition Solutions.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.